Ethanol moves closer to EU approval for disinfectant use

At its February 2026 meeting, the Biocidal Products Committee issued opinions supporting the approval of ethanol as an active substance in three important product types under the Biocidal Products Regulation. These include:

• Product type 1 — Human hygiene products such as hand disinfectants
• Product type 2 — Disinfectants and algaecides not intended for direct contact with humans or animals
• Product type 4 — Products used in food and feed areas

The Committee concluded that safe use has been demonstrated for all intended uses within these categories. This is a significant step for manufacturers who rely on ethanol as a primary antimicrobial agent, particularly in hand rubs, surface disinfectants and food area sanitation products.

What makes this development especially relevant is the Committee’s decision not to propose any new hazard classification for ethanol at this stage. Despite ongoing scientific debate around potential carcinogenic or reproductive effects, the BPC did not reach a conclusion that would trigger reclassification.

Why the Committee did not classify ethanol as carcinogenic or reprotoxic

The BPC’s position reflects a nuanced scientific assessment. Several factors prevented a definitive hazard conclusion:

• Insufficient dermal exposure data
  Although the applicant’s dossier was considered complete, it lacked robust dermal exposure studies. This is a critical gap because dermal contact is a primary exposure route for biocidal products, especially hand disinfectants.
• Inhalation studies not aligned with standard guidelines
  Available inhalation data did not meet current regulatory standards, limiting its value in a formal hazard assessment.
• Most evidence comes from alcoholic beverage consumption
  The majority of carcinogenicity and reproductive toxicity data relates to voluntary oral consumption of ethanol in alcoholic drinks. The Committee determined that this evidence is not directly applicable to biocidal uses, where exposure routes, concentrations and patterns differ significantly.
• New studies are underway
  Research focusing on more relevant exposure routes is in progress. The BPC acknowledged that these studies should ideally inform any future hazard classification. However, delaying the approval process until these studies are completed could create unnecessary disruption for the market.

This balanced approach allows the regulatory process to move forward while acknowledging that the scientific picture is still evolving.

What happens next in the EU regulatory process

With the BPC opinion adopted, the next steps follow the established Biocidal Products Regulation pathway:

• ECHA sends the opinion to the European Commission
  The Commission will prepare a draft Implementing Regulation proposing approval or non approval.
• EU Member States vote
  The draft is submitted to the Standing Committee on Biocidal Products for a vote.
• Formal adoption
  If supported, the Commission adopts the decision and it becomes legally binding across the EU.

If ethanol is approved, companies will need to apply for product authorisation either at national level or through Union authorisation. If ethanol is not approved, products containing it must be withdrawn from the EU market within the applicable transition periods.

For brands, regulatory teams and formulators, this means now is the time to review product portfolios, assess data readiness and prepare for authorisation pathways.

What this means for formulators and regulatory teams

Ethanol remains one of the most widely used active substances in hygiene and disinfection. Its broad spectrum antimicrobial activity, rapid evaporation and compatibility with many formulation systems make it a cornerstone of both consumer and professional disinfectant products.

The BPC’s supportive opinion offers several practical implications:

• Market stability
  Brands can continue to plan around ethanol based formulations without anticipating immediate hazard reclassification.
• Regulatory clarity
  Although some toxicological questions remain open, the pathway toward approval is clearer, allowing companies to prepare dossiers and authorisation strategies.
• Innovation opportunities
  With ethanol likely to remain available, formulators can continue to optimise sensorial profiles, skin compatibility, solvent systems and sustainability attributes without needing to pivot to alternative actives.
• Data expectations will rise
  The Committee’s comments on dermal and inhalation data signal that future submissions may require stronger exposure assessments. Companies preparing for product authorisation should anticipate more rigorous data requirements.

Why this update matters for the wider industry

The Biocidal Products Regulation is designed to ensure that all active substances used in disinfectants are safe, effective and scientifically justified. Ethanol’s evaluation has been closely watched because of its widespread use and the public health importance of disinfectants.

This latest development reinforces several industry wide themes:

• Regulatory decisions increasingly rely on exposure route relevance, not just hazard data
• The EU continues to prioritise science based decision making even when evidence is incomplete
• Market continuity for essential hygiene products remains a key consideration
• Companies must stay proactive in data generation and dossier quality

For organisations operating across beauty, personal care, healthcare and food hygiene, staying ahead of these regulatory shifts is essential for maintaining compliance and protecting market access.

Strengthen your regulatory strategy with expert support

If your organisation is preparing for biocidal product authorisation, reviewing ethanol based formulations or planning future compliance strategies, expert guidance can help you navigate the evolving regulatory landscape with confidence.

Olalla Consulting supports brands, manufacturers and consultancies with regulatory assessments, formulation strategy and scientific documentation that meet the highest standards of accuracy and traceability.

Explore how we can support your next regulatory milestone at www.olallaconsulting.com.